title: [In Process Citation].
mesh_terms: D000911:Antibodies, Monoclonal / Q000008:administration & dosage; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D002292:Carcinoma, Renal Cell / Q000188:drug therapy* / Q000473:pathology*; D005858:Germany; D006801:Humans; D007211:Indoles / Q000008:administration & dosage; D000074324:Ipilimumab; D007680:Kidney Neoplasms / Q000188:drug therapy* / Q000473:pathology*; D009361:Neoplasm Invasiveness; D009362:Neoplasm Metastasis; D000077594:Nivolumab; D011379:Prognosis; D011758:Pyrroles / Q000008:administration & dosage; D012955:Societies, Medical; D000077210:Sunitinib; D014572:Urology
chemical_list: D000911:Antibodies, Monoclonal; D007211:Indoles; D000074324:Ipilimumab; D011758:Pyrroles; D000077594:Nivolumab; D000077210:Sunitinib